Modi'in Makabim-Re'ut, Israel · Founded 2005 · Privately Held (backing)
Developer of a cancer drug intended to activate immune responses by converting cancer camouflage into beacons for the immune system to attack. KAHR Bio is based in Modi'in Makabim-Re'ut, Israel and was founded in 2005. Its last reported valuation was $166 million in Nov 2022. It has raised $183 million.
Last reported valuation
$165.7M
Oct 2026
Priced at
—
Total raised
$183.3M
Last round
—
Team — not yet on record
No current team members for KAHR Bio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of KAHR Bio with a free account
·The complete investor list: 19 names
·Watch KAHR Bio: the Monday email on marks, rounds and moves
